US Patent 9951069 Bicyclic inhibitors of histone deacetylase
Patent 9951069 was granted and assigned to Rodin Therapeutics on April, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 22 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+230 characters)
Article
Patent abstract
Provided herein are compounds and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of conditions associated with inhibition of HDAC (e.g., HDAC2).
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
John A. Lowe, II0
Nathan Oliver Fuller0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09951069 Bicyclic inhibitors of histone deacetylase US Patent 9951069 Bicyclic inhibitors of histone deacetylase
Infobox
Patent Number
099510690
Patent Number
99510690
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
099510690
Date of Patent
April 24, 2018
0Patent Application Number
158679820
Date Filed
January 11, 2018
0Patent Primary Examiner
Edits on 20 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09951069 Bicyclic inhibitors of histone deacetylase
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09951069
Date of patent
April 24, 2018
Patent application number
15867982
Date Filed
January 11, 2018
Patent primary examiner
Find more entities like US Patent 9951069 Bicyclic inhibitors of histone deacetylase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
